|
1
|
Morris PG, McArthur HL and Hudis CA:
Therapeutic options for metastatic breast cancer. Expert Opin
Pharmacother. 10:967–981. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brunello A, Roma A, Falci C and Basso U:
Chemotherapy and targeted agents for elderly women with advanced
breast cancer. Recent Pat Anticancer Drug Discov. 3:187–201. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gonzalez-Angulo AM, Morales-Vasquez F and
Hortobagyi GN: Overview of resistance to systemic therapy in
patients with breast cancer. Adv Exp Med Biol. 608:1–22. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hess KR, Varadhachary GR, Taylor SH, Wei
W, Raber MN, Lenzi R and Abbruzzese JL: Metastatic patterns in
adenocarcinoma. Cancer. 106:1624–1633. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zlotnik A: Involvement of chemokine
receptors in organ-specific metastasis. Contrib Microbiol.
13:191–199. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miao Z, Luker KE, Summers BC, Berahovich
R, Bhojani MS, Rehemtulla A, Kleer CG, Essner JJ, Nasevicius A,
Luker GD, Howard MC and Schall TJ: CXCR7 (RDC1) promotes breast and
lung tumor growth in vivo and is expressed on tumor-associated
vasculature. Proc Natl Acad Sci USA. 104:15735–15740. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Burns JM, Summers BC, Wang Y, Melikian A,
Berahovich R, Miao Z, Penfold ME, Sunshine MJ, Littman DR, Kuo CJ,
Wei K, McMaster BE, Wright K, Howard MC and Schall TJ: A novel
chemokine receptor for SDF-1 and I-TAC involved in cell survival,
cell adhesion, and tumor development. J Exp Med. 203:2201–2213.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zabel BA, Wang Y, Lewen S, Berahovich RD,
Penfold ME, Zhang P, Powers J, Summers BC, Miao Z, Zhao B, Jalili
A, Janowska-Wieczorek A, Jaen JC and Schall TJ: Elucidation of
CXCR7-mediated signaling events and inhibition of CXCR4-mediated
tumor cell transendothelial migration by CXCR7 ligands. J Immunol.
183:3204–3211. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chakraborti S, Mandal M, Das S, Mandal A
and Chakraborti T: Regulation of matrix metalloproteinases: an
overview. Mol Cell Biochem. 253:269–285. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sternlicht MD, Lochter A, Sympson CJ, Huey
B, Rougier JP, Gray JW, Pinkel D, Bissell MJ and Werb Z: The
stromal proteinase MMP3/stromelysin-1 promotes mammary
carcinogenesis. Cell. 98:137–146. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sternlicht MD, Bissell MJ and Werb Z: The
matrix metalloproteinase stromelysin-1 acts as a natural mammary
tumor promoter. Oncogene. 19:1102–1113. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Haupt LM, Irving RE, Weinstein SR, Irving
MG and Griffiths LR: Matrix metalloproteinase localisation by in
situ-RT-PCR in archival human breast biopsy material. Mol Cell
Probes. 22:83–89. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Haupt LM, Thompson EW, Trezise AE, Irving
RE, Irving MG and Griffiths LR: In vitro and in vivo MMP gene
expression localisation by in situ-RT-PCR in cell culture and
paraffin embedded human breast cancer cell line xenografts. BMC
Cancer. 6:182006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Markiewski MM and Lambris JD: Unwelcome
complement. Cancer Res. 69:6367–6370. 2009. View Article : Google Scholar : PubMed/NCBI
|
